Boehringer Ingelheim - South East Asia and South Korea

Industry: Pharmaceuticals
Area of excellence: Change management

The HR team at Boehringer Ingelheim South East Asia and South Korea (BI SEASK) has remained at the forefront of change management best practice initiatives in the past year. These have been critical to ensuring ongoing success following the major business swap of Sanofi’s animal health business (Merial) and BI’s consumer healthcare business in 2016.

One initiative, ‘OUR FOCUS’, is broadly designed to reshape corporate identity, work behaviours and business ambition for the year 2025. The specific HR components concentrate on areas related to people growth and rewards, in sync with a strong behavioural evolution. OUR FOCUS is founded upon three concepts related to how employees work: agility, accountability and intrapreneurship. The HR SEASK team has developed and executed actions and processes intended to socialise the changes through face-to-face ad hoc workshops, collating and sharing inspirational stories from employees and leaders who are demonstrating the new desired behaviours and giving visibility to behaviours in all HR processes.

Another initiative is ‘One Team and One Face’. In line with the organisation completing its first year of integration following the major business swap, this initiative has aimed to ensure all employees learn to operate as One Animal Health Team and provide just One Face to customers. The HR team – in a hand-by-hand collaboration with the business – has worked on setting new organisational structures while ensuring fair and transparent appointments for the new structures, aligning sales incentive plans for different units in different regions, and effectively infusing cultural elements from both companies.